BioNTech to build mRNA manufacturing site in Singapore

Image via BioNTech

BERLIN — BioNTech said on Monday it plans to set up a regional headquarters and build a new manufacturing site for its vaccines based on messenger RNA technology (mRNA) in Singapore, in the latest move to expand its production network. 

The biotech company said the Singapore production facility will have an estimated annual capacity of several hundred million doses of mRNA-based vaccines depending on the specific type, once it is operational in 2023. 

BioNTech said its expansion plans were supported by the Singapore Economic Development Board and would increase the global supply of mRNA-based vaccines and establish a production facility in south east Asia to respond rapidly to future pandemics. 

“Having multiple nodes in our production network is an important strategic step in building out our global footprint and capabilities,” said Ugur Sahin, chief executive officer and co-founder of BioNTech. 

Governments around the world are looking to

Read More

Federally funded mass vaccination site coming to Bon Carre business center

BATON ROUGE, La. (BRPROUD) – Friday, the White House announced the Bon Carre business center will become a mass vaccination site.

“It just makes sense logistically, you know we are right here on Florida Blvd, most people all throughout the parish can get here” said District 6 East Baton Rouge Metro Councilman, Cleve Dunn.

The plan is to bring shots directly to underserved communities.

“This is undoubtedly going to be a game changer in our fight against Covid 19” said East Baton Rouge Mayor-President, Sharon Weston Broome.

According to the White House, the site will be able to provide 3,000 shots per day for up to 8 weeks.

“Our Mass Vaccination sites located in some of the most underserved neighborhoods in the nation are run and staffed by FEMA and DOD staff in close partnership with state and local officials and these sites have a combined capacity to administer 110,000

Read More